News Briefing channel feed

Boris John­son pledges £250M to spur AI adop­tion in NHS; SQZ scoops CFO Teri Lox­am from Mer­ck

6 years ago

Athenex's oral chemother­a­py for­mu­la­tion scores in piv­otal study; Gly­comine brings in $33M in Se­ries B haul

6 years ago

FDA en­dors­es No­vavax's piv­otal tri­al de­sign for flu vac­cine; Forty Sev­en bags fund­ing for myelodys­plas­tic syn­dromes pro­gram

6 years ago

Guardant blood test shows promise in pre­dict­ing im­munother­a­py re­sponse; As­traZeneca's di­a­betes drug wins EU la­bel ex­pan­sion

6 years ago

Am­i­cus touts lat­est set of gene ther­a­py da­ta; No­vo Nordisk ex­pands dis­cov­ery deal for di­a­betes

6 years ago

At­lantic Health­care's drug fails late-stage test; Trans­late Bio breaks out ear­ly CF da­ta

6 years ago

Found­ing NewLink CEO Charles Link is out; Chi-Med lines up two more drug fil­ings

6 years ago

Gen­fit's elafi­bra­nor wins or­phan sta­tus for pri­ma­ry bil­iary cholan­gi­tis; Cidara stock soars on pos­i­tive an­ti-fun­gal mid-stage da­ta

6 years ago

EMA backs five med­i­cines; Sol­id Bio rais­es $60M in pri­vate place­ment

6 years ago

ICER backs cost-ef­fec­tive­ness of Vas­cepa, Xarel­to; Epizyme's lead drug wins speedy US re­view

6 years ago

WHO en­dors­es GSK's do­lute­gravir for HIV; Syapse col­lab­o­rates with Pfiz­er on RWE

6 years ago

Pro­teosta­sis shakes up med­ical team; No­vo funds an­tibi­otics ef­forts out of Curza, Spero

6 years ago

Ver­tex gets NDA go­ing for CF triple com­bo; Dis­arm woos rare dis­ease ex­pert Alvin Shih as CEO

6 years ago

Ap­peal re­ject­ed, Shkre­li stays in jail; MyoKar­dia brings for­ward piv­otal da­ta read­out

6 years ago

Seer en­tices ex FDA com­mis­sion­er Mc­Clel­lan to its board; Van­da tests tradip­i­tant in mo­tion sick­ness study

6 years ago

AI-fo­cused No­table Labs score $40M in fund­ing; Seat­tle Ge­net­ics/Astel­las sub­mit mar­ket­ing ap­pli­ca­tion for en­for­tum­ab ve­dotin

6 years ago

Alk­er­mes adds bipo­lar I dis­or­der to its FDA wish­list; Con­go con­firms first Ebo­la case in large city

6 years ago

Reckitt Benckiser shells $1.4B to set­tle US probe; NICE backs di­a­betes, pso­ri­a­sis treat­ments

6 years ago

Af­ter a rad­i­cal down­siz­ing, Te­va beefs up US R&D cam­pus; Tia­ki re­cruits Suzanne Bruhn for the helm

6 years ago

Sanofi be­gins count­down for FDA isat­ux­imab re­view; Cir­rho­sis-fo­cused biotech presents an­oth­er mi­ni IPO

6 years ago

Top Wood­ford lieu­tenant hits ex­it in shake­up; Roche posts more im­pres­sive da­ta on he­mo­phil­ia A drug

6 years ago

Sol-Gel's rosacea drug clears late-stage hur­dle; uniQure's he­mo­phil­ia gene ther­a­py im­press­es with PhII da­ta

6 years ago

GSK's Dova­to wins EU ap­proval; Red­Hill se­cures speedy re­view for H. py­lori drug

6 years ago

Got­tlieb re­buts Sci­ence re­port on plum­met­ing FDA in­spec­tions; Lib­tayo wins EMA and NICE en­dorse­ment

6 years ago
First page Previous page 47484950515253 Next page Last page
A service from the Financial Times